Search results for abx831403

Camrelizumab, Abbexa, abx831403

Camrelizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting PDCD1/PD-1/CD279, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Camrelizumab is under investigation in clinical trial NCT03417895 (SHR-1210 Combined With Apatinib in Treatment of ED-SCLC After Failure of First Line Standard Therapy).